Skip to main content

Table 2 Details of all subjects enrolled

From: Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial

Variable

Tocotrienols (n = 43)

Placebo (n = 44)

Pvalue

Gender (female)

23 (53.5%)

30 (68.2%)

0.160

Age in years (range)

52 ± 9 (36-74)

49 ± 7 (38-68)

0.177

BMI (kg/m2)

27.2 ± 4.6

27.1 ± 4.6

0.873

   Normoweight (BMI < 25)

16 (37.2%)

14 (31.8%)

 

  Overweight (25 < BMI < 30)

16 (37.2%)

21 (47.7%)

 

    Obese (30 < BMI < 40)

11 (25.6%)

8 (18.2%)

 

 Morbidly Obese (40 < BMI < 50)

0 (0.0%)

1 (2.3%)

 

TC (mmol/L)

5.9 ± 0.6

5.6 ± 0.6

0.075

HDL (mmol/L)

1.44 ± 0.35

1.37 ± 0.30

0.611

LDL (mmol/L)

3.7 ± 0.6

3.6 ± 0.6

0.168

TG (mmol/L)

1.5 ± 0.7

1.6 ± 0.8

0.889

ALP (IU/L)

76 ± 21

72 ± 18

0.826

AST (IU/L)

36 ± 14

38 ± 13

0.381

ALT (IU/L)

35 ± 16

39 ± 22

0.611

GGT (IU/L)

33 ± 19

32 ± 19

0.712

hs-Crp (mg/L)

4.3 ± 7.1

4.0 ± 5.4

0.865

Apo B (g/L)

1.25 ± 0.20

1.25 ± 0.21

0.952

Lp(A) (mg/dL)

17 ± 14

16 ± 16

0.449

Serum creatinine (μmol/L)

86 ± 13

78 ± 11

0.008

Fasting glucose (mmol/L)

5.4 ± 0.8

6.1 ± 2.3

0.557

      IFG ≥ 7.0 mmol/L

2 (4.7%)

7 (15.9%)

 

Systolic (mmHg)

134 ± 18

131 ± 15

0.524

Diastolic (mmHg)

80 ± 9

80 ± 9

0.976

Tobacco, current users

5 (11.6%)

5 (11.4%)

 

Mild NAFLD (score 3)

34 (79.1%)

35 (79.5%)

 

Moderate NAFLD (score 4)

7 (16.3%)

8 (18.2%)

 

Severe NAFLD (score 5-6)

2 (4.7%)

1 (2.3%)

 
  1. Baseline biochemical, anthropometric and clinical parameters of all patients enrolled in the study (n = 87). Data are expressed as mean value ± SD; P < 0.05 is considered significant.
  2. Table 2 Abbreviations: BMI  Body Mass Index, TC  Total Cholesterol, HDL High Density Lipoprotein, LDL Low Density Lipoprotein, TG Triglycerides, ALP Alkaline Phosphatase, AST aspartate transaminase, ALT alanine transaminase, GGT gamma-glutamyl transpeptidase, hs-CRP high-sensitivity C-reactive protein, ApoB apolipoprotein B, LP(A) lipoprotein A, IFG Impaired Fasting Glucose, NAFLD Nonalcoholic Fatty Liver Disease.
  3. [Wilcoxon rank test; Numbers’ 09, GraphPad].
  4. Conversion factor mmol/L to mg/dL for optimal normal values:
  5. TC 5.2 mmol/L = 200 mg/dL;
  6. HDL 1.55 mmol/L = 60 mg/dL;
  7. LDL 2.6 mmol/L = 100 mg/dL;
  8. TG 1.7 mmol/L = 151 mg/dL.